China · Delayed Price · Currency is CNY Newland Pharmaceutical Statistics
Total Valuation
SHE:301277 has a market cap or net worth of CNY 5.84 billion. The enterprise value is 5.18 billion.
| Market Cap | 5.84B |
| Enterprise Value | 5.18B |
Important Dates
The last earnings date was Tuesday, August 12, 2025.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | Apr 16, 2025 |
Share Statistics
SHE:301277 has 392.08 million shares outstanding. The number of shares has increased by 1.33% in one year.
| Current Share Class | 392.08M |
| Shares Outstanding | 392.08M |
| Shares Change (YoY) | +1.33% |
| Shares Change (QoQ) | -2.88% |
| Owned by Insiders (%) | 66.24% |
| Owned by Institutions (%) | 1.08% |
| Float | 89.15M |
Valuation Ratios
The trailing PE ratio is 41.64.
| PE Ratio | 41.64 |
| Forward PE | n/a |
| PS Ratio | 8.48 |
| PB Ratio | 3.87 |
| P/TBV Ratio | 4.01 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 61.77 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 27.01, with an EV/FCF ratio of -148.68.
| EV / Earnings | 36.97 |
| EV / Sales | 7.53 |
| EV / EBITDA | 27.01 |
| EV / EBIT | 35.55 |
| EV / FCF | -148.68 |
Financial Position
The company has a current ratio of 5.29, with a Debt / Equity ratio of 0.00.
| Current Ratio | 5.29 |
| Quick Ratio | 4.86 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.02 |
| Debt / FCF | -0.11 |
| Interest Coverage | 5,638.14 |
Financial Efficiency
Return on equity (ROE) is 9.40% and return on invested capital (ROIC) is 6.08%.
| Return on Equity (ROE) | 9.40% |
| Return on Assets (ROA) | 5.20% |
| Return on Invested Capital (ROIC) | 6.08% |
| Return on Capital Employed (ROCE) | 9.31% |
| Revenue Per Employee | 660,733 |
| Profits Per Employee | 134,513 |
| Employee Count | 1,042 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 8.73 |
Taxes
In the past 12 months, SHE:301277 has paid 15.54 million in taxes.
| Income Tax | 15.54M |
| Effective Tax Rate | 9.96% |
Stock Price Statistics
The stock price has increased by +55.47% in the last 52 weeks. The beta is 0.50, so SHE:301277's price volatility has been lower than the market average.
| Beta (5Y) | 0.50 |
| 52-Week Price Change | +55.47% |
| 50-Day Moving Average | 14.97 |
| 200-Day Moving Average | 12.35 |
| Relative Strength Index (RSI) | 48.82 |
| Average Volume (20 Days) | 14,012,419 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:301277 had revenue of CNY 688.48 million and earned 140.16 million in profits. Earnings per share was 0.36.
| Revenue | 688.48M |
| Gross Profit | 256.49M |
| Operating Income | 145.77M |
| Pretax Income | 155.99M |
| Net Income | 140.16M |
| EBITDA | 189.42M |
| EBIT | 145.77M |
| Earnings Per Share (EPS) | 0.36 |
Balance Sheet
The company has 660.76 million in cash and 3.72 million in debt, giving a net cash position of 657.04 million or 1.68 per share.
| Cash & Cash Equivalents | 660.76M |
| Total Debt | 3.72M |
| Net Cash | 657.04M |
| Net Cash Per Share | 1.68 |
| Equity (Book Value) | 1.51B |
| Book Value Per Share | 3.92 |
| Working Capital | 856.55M |
Cash Flow
In the last 12 months, operating cash flow was 94.51 million and capital expenditures -129.37 million, giving a free cash flow of -34.85 million.
| Operating Cash Flow | 94.51M |
| Capital Expenditures | -129.37M |
| Free Cash Flow | -34.85M |
| FCF Per Share | -0.09 |
Margins
Gross margin is 37.25%, with operating and profit margins of 21.17% and 20.36%.
| Gross Margin | 37.25% |
| Operating Margin | 21.17% |
| Pretax Margin | 22.66% |
| Profit Margin | 20.36% |
| EBITDA Margin | 27.51% |
| EBIT Margin | 21.17% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.29, which amounts to a dividend yield of 1.92%.
| Dividend Per Share | 0.29 |
| Dividend Yield | 1.92% |
| Dividend Growth (YoY) | 40.00% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 79.92% |
| Buyback Yield | -1.33% |
| Shareholder Yield | 0.63% |
| Earnings Yield | 2.40% |
| FCF Yield | -0.60% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 16, 2025. It was a forward split with a ratio of 1.4.
| Last Split Date | Apr 16, 2025 |
| Split Type | Forward |
| Split Ratio | 1.4 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |